Inventor

KLICHINSKY MICHAEL

US11 patents

⚠️ This page may combine multiple inventors who share the name “KLICHINSKY MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV PENNSYLVANIA

9 patents

US11034749B2Jun 15, 2021

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

UNIV PENNSYLVANIA10 citations93

US11306133B2Apr 19, 2022

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

UNIV PENNSYLVANIA1 citations72

US11498954B2Nov 15, 2022

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

UNIV PENNSYLVANIA0 citations62

US11407805B2Aug 9, 2022

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

UNIV PENNSYLVANIA0 citations62

US11359002B2Jun 14, 2022

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

UNIV PENNSYLVANIA0 citations62

US11332511B2May 17, 2022

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

UNIV PENNSYLVANIA0 citations62

US11325963B2May 10, 2022

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

UNIV PENNSYLVANIA0 citations62

US11319358B2May 3, 2022

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

UNIV PENNSYLVANIA0 citations62

US11306134B2Apr 19, 2022

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

UNIV PENNSYLVANIA0 citations62

CARISMA THERAPEUTICS INC

2 patents

US11312939B2Apr 26, 2022

Constructs for chimeric antigen receptors

CARISMA THERAPEUTICS INC2 citations62

US11739297B2Aug 29, 2023

Method of increasing tumor killing activity of macrophages or monocytes comprising chimeric antigen receptor

CARISMA THERAPEUTICS INC0 citations51